Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 10;16(1):4.
doi: 10.1186/s12916-017-0987-1.

Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study

Zoe Paskins  1   2 , Rebecca Whittle  3 , Alyshah Abdul Sultan  3 , Sara Muller  3 , Milica Blagojevic-Bucknall  3 , Toby Helliwell  3 , Samantha Hider  3   4 , Edward Roddy  3   4 , Christian Mallen  3
Affiliations

Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study

Zoe Paskins et al. BMC Med. .

Abstract

Background: Glucocorticoids are associated with increased fracture risk and are the mainstay of treatment in polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). However, fracture risk in these conditions has not been previously quantified. The aim of this study was to quantify the risk of fracture among patients with PMR and GCA.

Methods: A retrospective cohort study was conducted using primary care records from the UK-based Clinical Practice Research Datalink. Individuals aged 40 years and over, with incident diagnoses of PMR or GCA were separately identified from 1990-2004 and followed up until 2015. For each exposed individual, four age-, sex- and practice-matched controls were randomly selected. Incidence rates of fracture per 10,000 person-years were calculated for each disease group and hazard rates were compared to the unexposed using Cox regression models.

Results: Overall, 12,136 and 2673 cases of PMR and GCA, respectively, were identified. The incidence rate of fracture was 148.05 (95% CI 141.16-155.28) in PMR and 147.15 (132.91-162.91) in GCA per 10,000 person-years. Risk of fracture was increased by 63% in PMR (adjusted hazard ratio 1.63, 95% CI 1.54-1.73) and 67% in GCA (1.67, 1.49-1.88) compared to the control populations. Fewer than 13% of glucocorticoid-treated cases were prescribed bisphosphonates.

Conclusions: This study reports, for the first time, a similar increase in fracture risk for patients with PMR and GCA. More needs to be done to improve adherence to guidelines to co-prescribe bisphosphonates. Further research needs to identify whether lower glucocorticoid starting doses and/or aggressive dose reduction reduces fracture risk.

Keywords: Fracture; Giant cell arteritis; Glucocorticoids; Osteoporosis; Polymyalgia.

PubMed Disclaimer

Conflict of interest statement

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Incident rate ratios of fracture in GCA and PMR populations. Adjusted for confounding factors which affect the HR > 10%, from age, sex, BMI, alcohol consumption, smoking status, Charlson comorbidity index and PPI use
See this image and copyright information in PMC

References

    1. Fardet L, Petersen I, Nazareth I. Monitoring of patients on long-term glucocorticoid therapy: a population-based cohort study. Medicine (Baltimore) 2015;94(15):e647. doi: 10.1097/MD.0000000000000647. - DOI - PMC - PubMed
    1. Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B. Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nat Rev Rheumatol. 2017;13(10):578–92. doi: 10.1038/nrrheum.2017.142. - DOI - PubMed
    1. Van Staa T, Leufkens H, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000;15(6):993–1000. doi: 10.1359/jbmr.2000.15.6.993. - DOI - PubMed
    1. Van Staa T, Geusens P, Bijlsma J, Leufkens H, Cooper C. Clinical assessment of the long‐term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheumatism. 2006;54(10):3104–12. doi: 10.1002/art.22117. - DOI - PubMed
    1. Bultink I, Harvey N, Lalmohamed A, et al. Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the united kingdom. Osteoporosis Int. 2014;25(4):1275–83. doi: 10.1007/s00198-013-2587-z. - DOI - PubMed

Publication types

Substances